FDA Approved: WEGOVY — Supplemental Application (Novo Nordisk)

View source ↗

Summary

The FDA approved Novo Nordisk's supplemental application for Wegovy (semaglutide). This action expands its labeling to support chronic weight management in adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• WEGOVY (Semaglutide)

Snippet

SUPPL AP for WEGOVY (SEMAGLUTIDE)